'Bones' Back in the Hot-Seat

August 23, 2017

 

 

 

 

'We are all at a complete loss for words right now. Jon, his trainers, his nutritionists and his entire camp have worked tirelessly and meticulously the past 12 months to avoid this exact situation. We are having the samples tested again to determine the validity or source of contamination. Jon is crushed by this news and we are doing whatever we can as a team, to support him."

 

-Jon Jones' Manager

Malki Kawa

 

Light heavyweight champion Jon 'Bones' Jones recently tested positive for two banned substances: clomiphene and letrozol from results of tests that were taken at weigh ins before UFC 2017 that were released in recent reports (UFC hasn't confirmed substances yet). Jones previously tested positive for clomiphene before UFC 200 which he blamed on his use of a erectile dysfunction medication or "dick pill." Someone else also tested positive for the same substance during that time.  Multiple media outlets reported that former UFC heavyweight champion Brock Lesnar tested positive for clomiphene in two failed drug tests performed in connection with his UFC 200 co-headliner against Mark Hunt.

 

Hydroxy-clomiphene (a Clomid metabolite) is a selective estrogen-receptor modulator (SERM) and is used by steroid users after taking anabolic steroids in a post cycle therapy (PCT) protocol. This is a small drug program used to boost natural testosterone levels after they have been suppressed by androgen usage.

 

LetrozolLetrozole (Femera) is an anti-cancer drug, which lowers levels of estrogen. This drug is an aromatase inhibitor (AI) and blocks the conversion of testosterone to estrogen.

 

Both drugs are not performance enhancing drugs, as they don’t boost strength, power, stamina or muscle growth, but do boost testosterone in hypogondal males. They are, however, on the USADA and World Anti-Doping Agency banned lists. Their usage would indicate steroids were used prior, or the correction of low testosterone levels.

-Steroidal

 

TMZ reported that he tested positive once again for Turinabol.

 

With Turinabol athletes and bodybuilders can expect steady and quality lean mass gains with no risk of any bloating, gyno, or any other estrogenic effects. Mass and strength gains are not known to be dramatic due to its lack of anabolic strength, but steady and quality lean gains that grow consistently over time can be expected. It is also used as an ideal cutting agent during periods of fat loss or pre-contest preparation due to its inability to convert into Estrogen. Turinabol’s capabilities really shine as an adjunct to other anabolic steroids when it is run (stacked) with other anabolic steroids due to its ability to bind to SHBG. Binding to SHBG allows more of the other anabolic steroids it is stacked with to be available to do their job, being uninhibited by SHBG, which is another advantage that it exhibits.

 

 The UFC released the following statement below on the evening 8/22/2017:

 

The UFC organization was notified today that the U.S. Anti-Doping Agency (USADA) has informed Jon Jones of a potential Anti-Doping Policy violation stemming from an in-competition sample collected following his weigh-in on July 28, 2017.

USADA, the independent administrator of the UFC Anti-Doping Policy, will handle the results management and appropriate adjudication of this case involving Jones, as it relates to the UFC Anti-Doping Policy and future UFC participation. Under the UFC Anti-Doping Policy, there is a full and fair legal process that is afforded to all athletes before any sanctions are imposed. The California State Athletic Commission (CSAC) also retains jurisdiction over this matter as the sample collection was performed the day before Jones’ bout at UFC 214 in Anaheim, CA, and USADA will work to ensure that the CSAC has the necessary information to determine its proper judgment of Jones’ potential anti-doping violation.

Additional information will be provided at the appropriate time as the process moves forward.

 

 

“The California State Athletic Commission has been made aware of Jon Jones’ test results and is looking into the matter,” CSAC executive officer Andy Foster said.

 

 

The USADA statement reads:

 

Given that Mr. Jones’ representative has publicly commented on the case, USADA can confirm that he has been notified of a potential anti-doping policy violation stemming from an in-competition sample he provided after his weigh-in on July 28, 2017. Because this is an ongoing case, at this time we are not going to provide any further details.

 

Both statements were told to MMA Fighting.com

 

 

It's not clear if Dan Cormier will get his belt back. Jones faces a four year suspension after his title is stripped. The real question is why? Why would someone who's been regarded as the best in the game for so long continually resort to trying these substances? It brings forth another question: How long has this been happening? USADA has recently changed their procedures within the last 2 years and you can see their protocol at the bottom of the page. Has that allowed them to reveal things they've missed in the past or has Jones developed an addiction to PED's within the last 3 years? He has (against his coaches advice incorporated some powerlifting into his routines). The powerlifting communities are heavily favored on steroid usage for overall strength gains in the recovery process. 

 

Though this is MMA not powerlifting. In this sport athletes can and will inflict damage to each other so to have a competitive edge is extremely unfair compared to baseball where one team can get a few more home runs a fighter could walk away with serious injuries.

 

The bottom line is that this is a shocking development but still something that isn't new to this still evolving sport.  

 

USADA protocol

 

 

 

 

 

 

 

 

 

 

 

Share on Facebook
Share on Twitter
Please reload

© 2017 Created by CrossFace Productions

  • Facebook Social Icon
  • Twitter Social Icon
  • Instagram Social Icon